Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans
Part of paid clinical trials in San Diego, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05770479
- Status
- Enrolling By Invitation
Conditions
- Mild Cognitive Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Motivationally-Enhanced Compensatory Cognitive Training (ME-CCT) Booster Modules — BEHAVIORALME-CCT is a traditionally a manualized group-based behavioral intervention (8 weeks, 2 hours per week) designed to improve cognitive and everyday functioning in patients with MCI. Our booster modules will be shortened and distilled from ME-CCT using the IM Adapt protocol (and thus will not be new information but rather 'reminder' content) for a personalized four-session sequence of booster training targeted toward specific everyday functional needs of individual participants.
- Treatment As Usual — OTHERTreatment for MCI is generally managed by Primary Care or Neurology. Participants will continue to receive their usual care with their current providers. With no effective pharmacological treatment known for persons with MCI, providers tend to focus on encouraging a healthy lifestyle, prevention and management of modifiable risk factors for cognitive impairment, and treatment of behavioral and psychiatric symptoms.
Study Details
Veterans have numerous risk factors (e.g., PTSD, TBI, cerebrovascular problems) for later-life cognitive and functional decline. Evidence supports the effectiveness of strategy-based cognitive rehabilitation therapies, including compensatory cognitive training (CCT), for such decline. However, questions remain about the length of time that CCT-driven improvements in cognitive and everyday function last, and whether additional 'booster' training sessions could provide additional benefit to aging Veterans who previously underwent treatment. This study examines the long-term durability of CCT in Veterans aged 55+ and provides an opportunity to develop and pilot test a series of CCT booster sessions that can be personalized toward individual everyday functional goals.
Key Dates
- Start date
- Jul 1, 2023
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 28 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: ME-CCT Booster Training3-4 Sessions of ME-CCT Booster Training
- Other: Treatment as UsualTreatment as Usual
Primary Outcome Measure
"Acceptability of Intervention Measure (AIM)" questionnaire mean score [ Time Frame: 4 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA San Diego Healthcare System, San Diego, CA | San Diego | California | 92161-0002 | - |
Find similar trials in San Diego, CA
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay DementiaRecruiting · University of Alabama at Birmingham · San Francisco, California
- The Digital Memory NotebookEnrolling By Invitation · University of California, Davis · Sacramento, California
- Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of ADPHASE1 · Recruiting · Butler Hospital · Los Angeles, California